Hormone blocker aims to pause early puberty in children
Disease control
Ongoing
This trial tests a long-acting injection of leuprolide acetate in children with central precocious puberty, a condition where puberty starts too early. The goal is to suppress puberty-related hormones, slowing or stopping early development. The study includes children aged 4 to 9…
Phase: PHASE4 • Sponsor: HanAll BioPharma Co., Ltd. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC